SS-31

SS-31 (also known as Elamipretide, Bendavia, MTP-131) is a prominently researched experimental compound classified strictly within the Mitochondrial Peptide framework. Operating primarily through advanced pharmacological pathways, its core mechanism of action is as follows: it mitochondrial protection. Selectively concentrates in the inner mitochondrial membrane where it stabilizes cardiolipin for efficient electron transport chain function. with a documented biological half-life of roughly 4 hours, In preclinical investigative trials and independent academic studies, researchers utilizing SS-31 have documented significant, quantifiable biological outcomes, primarily focusing on energy, recovery, neuroprotection. Typical research protocols investigate administering 4000 to 4000mcg via subq pathways 7x/wk. However, it is critically important to understand that while SS-31 demonstrates profound physiological potential in highly controlled laboratory settings, it remains classified strictly as a research chemical and has not been approved by the United States Food and Drug Administration (FDA) for human therapeutic, diagnostic, or dietary consumption. Independent chemical analysis via rigorous third-party Certificate of Analysis (COA) testing utilizing High-Performance Liquid Chromatography (HPLC) and Mass Spectrometry (MS) remains the industry gold standard for verifying its base elemental stability when reconstituted appropriately in sterile bacteriostatic water.